Limits of the applicability and generalizability of drug trials in mania

Bipolar Disorders

Volumn 4, Issue SUPPL. 1, 2002, Pages 66-68

  Licht, Ramus W ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antimanic agents; Bipolar disorder; Drug therapy; Generalizability; Methodology; Randomized controlled trials

Indexed keywords

CHLORPROMAZINE; LITHIUM; PLACEBO; RISPERIDONE; VALPROIC ACID; ZUCLOPENTHIXOL;

AGGRESSIVENESS; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG APPROVAL; DRUG INFORMATION; HUMAN; MANIA; METHODOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCREENING; VALIDATION PROCESS;

ANTIMANIC AGENTS; BIPOLAR DISORDER; HUMANS; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SAMPLE SIZE;

EID: 0036382274     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.4.s1.27.x     Document Type: Article

References (13)

1. Licht RW. Drug treatment of mania: a critical review. Acta Psychiatr Scand 1998; 97: 387-397.
2. Elwood JM. Selection of subjects for study. In: Elwood, JM, ed. Causal Relationships in Medicine. Oxford: Oxford University Press 1988, 38-57.
3. Gouliaev G, Licht RW, Vestergaard P et al. Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. Acta Psychiatr Scand 1996; 93: 119-124.
4. Licht RW, Gouliaev G, Vestergaard P et al. Generalisability of results from randomised drug trials. A trial on antimanic treatment. Br J Psychiatry 1997; 170: 264-267.
5. Licht RW, Bysted M, Christensen H. Fixed-dosed risperidone in mania: an open experimental trial. Int Clin Psychopharmacol 2001; 16: 103-110.
6. European Rating Aggression Group (ERAG). Social Dysfunction and Agression Scale (SDAS-21) in generalized aggression and aggressive attacks: a validity and reliability study. Int J Meth Psychiatr Res 1992; 2: 15-29.
7. Prien RF, Caffey EM Jr, Klett CJ. Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch General Psychiatry 1972; 26: 146-153.
8. Tohen M, Jacobs TG, Grundy SL et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch General Psychiatry 2000; 57: 841-849.
9. Pope HG Jr, McElroy SL, Keck PE Jr. et al. Valproate in the treatment of acute mania. Arch General Psychiatry 1991; 48: 62-68.
10. Bowden CL, Brugger AM, Swann AC et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994; 271: 918-924.
11. Tohen M, Sanger TM, McElroy SL et al. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 1999; 156: 702-709.
12. Licht RW. Limitations in randomised controlled trials evaluating drug effects in mania. Eur Arch Psychiatry Clin Neurosci 2001; 251 (Suppl. 2): 66-71.
13. European College of Neuropsychopharmacology. ECNP Consensus Meeting, March 2000, Nice: guidelines for investigating efficacy in bipolar disorder. Eur Neuropsychopharmacol 2001; 11: 79-88.